Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-09-013629
Filing Date
2009-09-24
Accepted
2009-09-24 16:51:19
Documents
2
Period of Report
2009-09-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 11070
2 exhibit24.txt EX-24.1 3026
  Complete submission text file 0001179110-09-013629.txt   16009
Mailing Address 1180 AVENUE OF THE AMERICA 19TH FLOOR NEW YORK NY 10036
Business Address 1180 AVENUE OF THE AMERICA 19TH FLOOR NEW YORK NY 10036 646-214-0700
ZIOPHARM ONCOLOGY INC (Issuer) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8093 Services-Specialty Outpatient Facilities, NEC

Mailing Address C/O FRAGIN ASSET MANAGEMENT 4925 ARLINGTON AVENUE RIVERDALE NY 10471
Business Address
FRAGIN GARY S (Reporting) CIK: 0001338534 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33038 | Film No.: 091085389